Pfizer to strengthen R&D operations in central, western China

11/25/2009 | Reuters

Pfizer (China) Research and Development will collaborate with the Wuhan National Bioindustry Base Construction and Management Office to build a site for research and development as part of a plan to expand in central and western China. The companies will also renovate Pfizer's research facility in Shanghai to support clinical trials.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care